Artios Pharma Publishes Preclinical Data on The First Selective Small Molecule Polθ Polymerase Inhibitor in Nature Communications

NEXT STORY
BeyondSpring to Host R&D Day to Discuss Novel Immune Agent Plinabulin’s Development Program in Anti-cancer Indications
PREV STORY
Next Super Stocks on the Move: AI/ML Innovations (OTC: AIMLF), Red Light Holland (OTC: TRUFF), Victory Square Technologies (OTC: VSQTF), and Reliq Health Tech (OTC: RQHTF)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Z-Medica Commends Tucson Police Department for Trauma Kit Utilization

WALLINGFORD, Conn., June 3, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Z-Medica®, LLC, a ...

author_avatar
NASDAQ Market News

Hemostemix Formalizes World-Class Scientific Advisory Board

CALGARY, Alberta, July 05, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) ...

author_avatar
NASDAQ Market News

Bavarian Nordic Announces 3:1 Effective Split of American Depositary Shares

COPENHAGEN, Denmark, January 5, 2016 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced ...

author_avatar
NASDAQ Market News